Detection of minimal residual disease following induction immunochemotherapy predicts progression free survival in mantle cell lymphoma: final results of CALGB 59909

BACKGROUND: In the present study, the prognostic impact of minimal residual disease during treatment on time to progression and overall survival was analyzed prospectively in patients with mantle cell lymphoma treated on the Cancer and Leukemia Group B 59909 clinical trial. DESIGN AND METHODS: Perip...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Liu, Hongtao, Johnson, Jeffrey L., Koval, Greg, Malnassy, Greg, Sher, Dorie, Damon, Lloyd E., Hsi, Eric D., Bucci, Donna Marie, Linker, Charles A., Cheson, Bruce D., Stock, Wendy
Natura: Artigo
Lingua:Inglês
Pubblicazione: Ferrata Storti Foundation 2012
Soggetti:
Original Articles and Brief Reports
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3347669/
https://ncbi.nlm.nih.gov/pubmed/22102709
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2011.050203
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi